MYbiotech was founded in 2013, adhering to the corporate spirit of "serving scientific research, assisting doctors, and protecting lives". MYbiotech is committed to becoming a core participant in the field of In-Vitro Diagnostic, dedicated in innovating diagnostic technology for nervous system immune disease and infection. Integrating R&D, manufacture, sales of diagnostic reagents and instrument and ICL service together, Mybiotech is recognized as an Innovative biological national high-tech enterprise.